Immediate need for next-generation and mutation-proof vaccine to protect against current emerging Omicron sublineages and future SARS-CoV-2 variants: An urgent call for researchers and vaccine companies - Correspondence.
Int J Surg
; 106: 106903, 2022 10.
Article
in English
| MEDLINE | ID: covidwho-2028117
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vaccines
/
COVID-19
Topics:
Vaccines
/
Variants
Limits:
Humans
Language:
English
Journal:
Int J Surg
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS